I help growth-oriented life sciences companies, investors, and academic institutions maximize IP asset value through strategic patent portfolio development counseling in transactions and disputes.
Dr. Philip Choi has obtained numerous domestic and foreign patents for corporate, academic and independent research institutions in a wide range of technical areas, including the fields of biotechnology, biochemistry, materials science, biomedicine and pharmaceuticals.
Philip specializes in helping academic institutions with cost-effective drafting and prosecution of pre-licensed patent applications, as well as representing institutional interests in the licensing and marketing of intellectual property available for technology transfer. In addition, he has extensive experience consulting on patent enforcement and litigation matters from discovery and deposition phases through to trial.
Philip brings extensive technical accomplishments in the life sciences to his intellectual property practice. As a doctoral student in the laboratory of Dr. Catherine Dulac at Harvard University and the Howard Hughes Medical Institute, he investigated the functions of microRNAs during the developmental regulation of olfactory neurogenesis in both mouse and zebrafish model systems using transgenic, exo utero electroporation and morpholino-mediated gene knockdown strategies. Philip also worked as a Howard Hughes Medical Institute undergraduate researcher with Dr. Robert Goldberg at the University of California, Los Angeles. In that capacity, he explored the role of morphogenetic factors involved in cell specification events that dictate differential developmental pathways during seed development using microarray, bioinformatics and reverse genetic strategies. Philip was a technology specialist and registered patent agent with the firm prior to and during his attendance of law school.